Confusion in a 13-Year-Old on 30% High-Flow Oxygen for 24 Hours
A 13-year-old receiving 30% FiO₂ via high-flow oxygen for 24 hours should NOT develop confusion from the oxygen therapy itself, as this concentration is well within safe physiologic ranges and does not cause oxygen toxicity or hyperoxemia-related neurologic symptoms at this level and duration.
Understanding the Clinical Context
The confusion upon waking requires investigation for other causes rather than attributing it to the oxygen therapy:
Why 30% Oxygen is Not the Culprit
Normal oxygen saturation targets: For children ≥1 year old (which includes your 13-year-old), normal SpO₂ during wakefulness is 97.6% (±0.7%), with acceptable desaturation nadirs during sleep reaching 93-94% 1
30% FiO₂ is minimally supplemental: This represents only 9% above room air (21% oxygen). Studies demonstrate that 30% oxygen administration actually improves cognitive performance rather than impairs it, with enhanced verbal accuracy and increased blood oxygen saturation without adverse neurologic effects 2
No hyperoxemia risk at this level: Research in mechanically ventilated children shows that 30% FiO₂ is considered a low oxygen exposure level. Even in post-resuscitation patients, 30% oxygen maintained adequate oxygenation without causing neuronal injury markers to rise 3
Duration is not concerning: While prolonged hyperoxemia (PaO₂ >100 torr) can contribute to organ injury 4, 30% FiO₂ for 24 hours does not typically produce supraphysiologic oxygen levels that would cause confusion
What You Should Actually Investigate
The confusion likely stems from the underlying illness requiring oxygen therapy or other complications:
Primary Differential Considerations:
Hypoxemia from the underlying condition
Hypercapnia (CO₂ retention)
- More likely culprit for confusion than oxygen therapy
- Check arterial or capillary CO₂ levels
Sepsis/infection causing delirium
Medication effects (sedatives, analgesics)
Sleep deprivation in the ICU environment
Metabolic derangements (glucose, electrolytes, ammonia)
Critical Pitfall to Avoid:
Do not reduce oxygen therapy based on concern about "too much oxygen" at 30% FiO₂. The guidelines emphasize that untreated hypoxemia has serious consequences on pulmonary circulation, neurodevelopment, cognition, sleep, and growth 1. At 30% FiO₂, you are providing modest supplementation that prevents these complications.
Clinical Action Plan
Immediate assessment should include:
- Pulse oximetry to confirm adequate oxygenation (target SpO₂ >93%)
- Blood gas analysis if SpO₂ monitoring suggests hypoxemia or if CO₂ retention suspected
- Neurologic examination for focal deficits
- Review of medications and timing
- Assessment for signs of infection/sepsis
- Basic metabolic panel
The 30% oxygen should be continued as prescribed for the underlying respiratory condition, as this level poses no risk of oxygen toxicity and confusion is not a recognized complication of this modest supplementation 2, 3.